<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The purpose of this study was to examine what levels of <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> cause blood-brain barrier (<z:chebi fb="2" ids="33602">BBB</z:chebi>) disruption during permanent and transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> in the rat and when the adverse effects of <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> occur </plain></SENT>
<SENT sid="1" pm="."><plain>Cerebrovascular function was assessed by measuring the influx rate constant (K(i)) for (3)H-<z:chebi fb="0" ids="15443">inulin</z:chebi> and by measuring cerebral plasma ((14)C-<z:chebi fb="0" ids="15443">inulin</z:chebi>) and (51)Cr-labeled red blood cell (RBC) volume </plain></SENT>
<SENT sid="2" pm="."><plain>Different <z:chebi fb="105" ids="17234">glucose</z:chebi> protocols were used to produce mild sustained <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> (blood <z:chebi fb="105" ids="17234">glucose</z:chebi> approximately 150 mg/dL) or transient-severe <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> (with a spike in blood <z:chebi fb="105" ids="17234">glucose</z:chebi> of approximately 400 mg/dL) </plain></SENT>
<SENT sid="3" pm="."><plain>As expected, transient-severe <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> at the time of occlusion induced marked <z:chebi fb="2" ids="33602">BBB</z:chebi> disruption in animals undergoing 2 h of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> with 2 h of reperfusion (25-fold increase in permeability compared with the contralateral core) </plain></SENT>
<SENT sid="4" pm="."><plain>However, the mild <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> model induced similar disruption </plain></SENT>
<SENT sid="5" pm="."><plain>Similarly, after permanent occlusion, both <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> models enhanced disruption and they both produced marked ( approximately 50%) reductions in cerebral plasma volume </plain></SENT>
<SENT sid="6" pm="."><plain>Apparent cerebral RBC volume also decreased when measured during the final 5 mins of 2 h of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> with transient-severe <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>However, there was no decrease if the (51)Cr-labeled RBCs were circulated for the whole 2 h, indicating RBC trapping </plain></SENT>
<SENT sid="8" pm="."><plain>The spike in blood <z:chebi fb="105" ids="17234">glucose</z:chebi> in the severe <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> model was used to examine when <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> induced <z:chebi fb="2" ids="33602">BBB</z:chebi> disruption </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0003074'>Hyperglycemia</z:hpo> shortly after occlusion caused severe disruption </plain></SENT>
<SENT sid="10" pm="."><plain>In contrast, <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> after 90 mins of occlusion caused little disruption </plain></SENT>
<SENT sid="11" pm="."><plain>These results suggest that mild <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> has a profound effect on <z:chebi fb="2" ids="33602">BBB</z:chebi> function and that very early correction of <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> is necessary to prevent adverse effects </plain></SENT>
</text></document>